A pathogenic variant in RAB32 causes autosomal dominant Parkinson’s disease and activates LRRK2 kinase
View ORCID ProfileEmil K. Gustavsson, View ORCID ProfileJordan Follett, View ORCID ProfileJoanne Trinh, View ORCID ProfileSandeep K. Barodia, View ORCID ProfileRaquel Real, View ORCID ProfileZhiyong Liu, View ORCID ProfileMelissa Grant-Peters, View ORCID ProfileJesse D. Fox, View ORCID ProfileSilke Appel-Cresswell, View ORCID ProfileA. Jon Stoessl, View ORCID ProfileAlex Rajput, Ali H. Rajput, View ORCID ProfileRoland Auer, View ORCID ProfileRussel Tilney, View ORCID ProfileMarc Sturm, View ORCID ProfileTobias B. Haack, View ORCID ProfileSuzanne Lesage, View ORCID ProfileChristelle Tesson, View ORCID ProfileAlexis Brice, Carles Vilariño-Güell, View ORCID ProfileMina Ryten, View ORCID ProfileMatthew S. Goldberg, View ORCID ProfileAndrew B. West, View ORCID ProfileMichele T. Hu, View ORCID ProfileHuw R. Morris, Manu Sharma, View ORCID ProfileZiv Gan-Or, View ORCID ProfileBedia Samanci, View ORCID ProfilePawel Lis, View ORCID ProfileTeresa Tocino, View ORCID ProfileRim Amouri, View ORCID ProfileSamia Ben Sassi, Faycel Hentati, Global Parkinson’s Genetics Program (GP2), View ORCID ProfileFrancesca Tonelli, View ORCID ProfileDario R. Alessi, View ORCID ProfileMatthew J. Farrer
doi: https://doi.org/10.1101/2024.01.17.24300927
Emil K. Gustavsson
1Department of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK
7Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
26Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA
Jordan Follett
2McKnight Brain Institute, Department of Neurology, University of Florida, Gainesville, Florida, USA
7Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
Joanne Trinh
3Institute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, Lübeck 23538, Germany
7Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
Sandeep K. Barodia
4Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA
Raquel Real
5Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK
6UCL Movement Disorders Centre, University College London, London WC1N 3BG, UK
26Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA
Zhiyong Liu
4Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA
Melissa Grant-Peters
1Department of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK
25MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK
Jesse D. Fox
7Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
Silke Appel-Cresswell
8Pacific Parkinson’s Research Centre, Djavad Mowafaghian Centre for Brain Health, Division of Neurology, University of British Columbia, Vancouver, BC, Canada
A. Jon Stoessl
8Pacific Parkinson’s Research Centre, Djavad Mowafaghian Centre for Brain Health, Division of Neurology, University of British Columbia, Vancouver, BC, Canada
Alex Rajput
9Movement Disorders Program, Division of Neurology, University of Saskatchewan and Saskatchewan Health Authority, Saskatoon, SK, Canada
Ali H. Rajput
9Movement Disorders Program, Division of Neurology, University of Saskatchewan and Saskatchewan Health Authority, Saskatoon, SK, Canada
Roland Auer
10Department of Pathology, University of Saskatchewan and Saskatchewan Health Authority, Saskatoon, SK, Canada
Russel Tilney
5Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK
6UCL Movement Disorders Centre, University College London, London WC1N 3BG, UK
Marc Sturm
11Institute for Medical Genetics and Applied Genomics, University of Tübingen, Germany
Tobias B. Haack
11Institute for Medical Genetics and Applied Genomics, University of Tübingen, Germany
Suzanne Lesage
12Sorbonne Université, Institut du Cerveau–Paris Brain Institute–ICM, Inserm, CNRS, Paris, France
Christelle Tesson
12Sorbonne Université, Institut du Cerveau–Paris Brain Institute–ICM, Inserm, CNRS, Paris, France
Alexis Brice
12Sorbonne Université, Institut du Cerveau–Paris Brain Institute–ICM, Inserm, CNRS, Paris, France
13Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Département de Neurologie, Centre d’Investigation Clinique Neurosciences, DMU Neuroscience, Paris, France
Carles Vilariño-Güell
14Department of Medical Genetics, University of British Columbia, Vancouver V6T 1Z3, Canada
Mina Ryten
1Department of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK
15NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London WC1N 1EH, UK
26Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA
Matthew S. Goldberg
4Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA
Andrew B. West
16Duke Center for Neurodegeneration and Neurotherapeutics, Department of Pharmacology and Cancer Biology, Duke University, 3 Genome Court, Durham 27710, North Carolina, USA
Michele T. Hu
17Division of Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford, UK
Huw R. Morris
5Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK
6UCL Movement Disorders Centre, University College London, London WC1N 3BG, UK
26Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA
Manu Sharma
18Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Germany
Ziv Gan-Or
Bedia Samanci
19The Neuro (Montreal Neurological Institute-Hospital), Montreal, Quebec, Canada
20Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
21Department of Human Genetics, McGill University, Montreal, Quebec, Canada
22Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
Pawel Lis
25MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK
26Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA
Teresa Tocino
23Queen Mary College, University of London, UK
Rim Amouri
24Service de Neurologie, Institut National de Neurologie, La Rabta, Tunis 1007, Tunisia
Samia Ben Sassi
24Service de Neurologie, Institut National de Neurologie, La Rabta, Tunis 1007, Tunisia
Faycel Hentati
24Service de Neurologie, Institut National de Neurologie, La Rabta, Tunis 1007, Tunisia
Francesca Tonelli
25MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK
26Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA
Dario R. Alessi
25MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK
26Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA
Matthew J. Farrer
2McKnight Brain Institute, Department of Neurology, University of Florida, Gainesville, Florida, USA
7Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
Data Availability
All GP2 data are hosted in collaboration with the Accelerating Medicines Partnership in Parkinsons Disease and are available via application on the website. All Genomics England data are hosted in a cloud workspace called the Research Environment. To access the data, researchers must first apply to become a member of either the Genomics England Clinical Interpretation Partnership (academics, students, and clinicians) or the Discovery Forum (industry partners). All AMP-PD data is available through https://www.amp-pd.org/ and requires access approval. Data from the German clinical diagnostic database will be made available upon request (manu.sharma{at}uni-tuebingen.de).
Posted January 18, 2024.
A pathogenic variant in RAB32 causes autosomal dominant Parkinson’s disease and activates LRRK2 kinase
Emil K. Gustavsson, Jordan Follett, Joanne Trinh, Sandeep K. Barodia, Raquel Real, Zhiyong Liu, Melissa Grant-Peters, Jesse D. Fox, Silke Appel-Cresswell, A. Jon Stoessl, Alex Rajput, Ali H. Rajput, Roland Auer, Russel Tilney, Marc Sturm, Tobias B. Haack, Suzanne Lesage, Christelle Tesson, Alexis Brice, Carles Vilariño-Güell, Mina Ryten, Matthew S. Goldberg, Andrew B. West, Michele T. Hu, Huw R. Morris, Manu Sharma, Ziv Gan-Or, Bedia Samanci, Pawel Lis, Teresa Tocino, Rim Amouri, Samia Ben Sassi, Faycel Hentati, Global Parkinson’s Genetics Program (GP2), Francesca Tonelli, Dario R. Alessi, Matthew J. Farrer
medRxiv 2024.01.17.24300927; doi: https://doi.org/10.1101/2024.01.17.24300927
A pathogenic variant in RAB32 causes autosomal dominant Parkinson’s disease and activates LRRK2 kinase
Emil K. Gustavsson, Jordan Follett, Joanne Trinh, Sandeep K. Barodia, Raquel Real, Zhiyong Liu, Melissa Grant-Peters, Jesse D. Fox, Silke Appel-Cresswell, A. Jon Stoessl, Alex Rajput, Ali H. Rajput, Roland Auer, Russel Tilney, Marc Sturm, Tobias B. Haack, Suzanne Lesage, Christelle Tesson, Alexis Brice, Carles Vilariño-Güell, Mina Ryten, Matthew S. Goldberg, Andrew B. West, Michele T. Hu, Huw R. Morris, Manu Sharma, Ziv Gan-Or, Bedia Samanci, Pawel Lis, Teresa Tocino, Rim Amouri, Samia Ben Sassi, Faycel Hentati, Global Parkinson’s Genetics Program (GP2), Francesca Tonelli, Dario R. Alessi, Matthew J. Farrer
medRxiv 2024.01.17.24300927; doi: https://doi.org/10.1101/2024.01.17.24300927
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2876)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12600)
- Forensic Medicine (10)
- Gastroenterology (810)
- Genetic and Genomic Medicine (4473)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2865)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4231)
- Nursing (226)
- Nutrition (619)
- Oncology (2217)
- Ophthalmology (630)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6817)
- Radiology and Imaging (1501)
- Respiratory Medicine (906)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)